Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas

Antoni, 2007, CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?, Nat. Rev. Cancer, 7, 925, 10.1038/nrc2251

Bao, 2006, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, 444, 756, 10.1038/nature05236

Bartek, 2003, Chk1 and Chk2 kinases in checkpoint control and cancer, Cancer Cell, 3, 421, 10.1016/S1535-6108(03)00110-7

Bartek, 2007, DNA damage signalling guards against activated oncogenes and tumour progression, Oncogene, 26, 7773, 10.1038/sj.onc.1210881

Bartkova, 2005, DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis, Nature, 434, 864, 10.1038/nature03482

Bartkova, 2006, Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints, Nature, 444, 633, 10.1038/nature05268

Bartkova, 2007, DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours, Oncogene, 26, 7414, 10.1038/sj.onc.1210553

Bartkova, 2010, Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas, Oncogene, 29, 5095, 10.1038/onc.2010.249

Bencokova, 2009, ATM activation and signaling under hypoxic conditions, Mol. Cell. Biol., 29, 526, 10.1128/MCB.01301-08

Bleau, 2008, New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans, Neurosurg. Focus, 24, E28, 10.3171/FOC/2008/24/3-4/E27

Brat, 2004, Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population, Cancer Res., 64, 920, 10.1158/0008-5472.CAN-03-2073

Brennan, 2009, Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations, PLoS ONE, 4, e7752, 10.1371/journal.pone.0007752

Bristow, 2008, Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability, Nat. Rev. Cancer, 8, 180, 10.1038/nrc2344

Charles, 2010, Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells, Cell Stem Cell, 6, 141, 10.1016/j.stem.2010.01.001

Cybulski, 2004, CHEK2 is a multiorgan cancer susceptibility gene, Am. J. Hum. Genet., 75, 1131, 10.1086/426403

Dai, 2001, PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo, Genes Dev., 15, 1913, 10.1101/gad.903001

Durocher, 2001, DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?, Curr. Opin. Cell Biol., 13, 225, 10.1016/S0955-0674(00)00201-5

Freiberg, 2006, DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response, Mol. Cell. Biol., 26, 1598, 10.1128/MCB.26.5.1598-1609.2006

Galli, 2004, Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma, Cancer Res., 64, 7011, 10.1158/0008-5472.CAN-04-1364

Gibson, 2005, Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner, Cancer Res., 65, 10734, 10.1158/0008-5472.CAN-05-1160

Gibson, 2006, CHK2-dependent phosphorylation of BRCA1 in hypoxia, Radiat. Res., 166, 646, 10.1667/RR0660.1

Gorgoulis, 2005, Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions, Nature, 434, 907, 10.1038/nature03485

Hambardzumyan, 2008, Glioma formation, cancer stem cells, and akt signaling, Stem Cell Rev., 4, 203, 10.1007/s12015-008-9021-5

Hammond, 2003, ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation, J. Biol. Chem., 278, 12207, 10.1074/jbc.M212360200

Hirao, 2000, DNA damage-induced activation of p53 by the checkpoint kinase Chk2, Science, 287, 1824, 10.1126/science.287.5459.1824

Hirao, 2002, Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner, Mol. Cell. Biol., 22, 6521, 10.1128/MCB.22.18.6521-6532.2002

Hirose, 2005, Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence, Cancer Res., 65, 4861, 10.1158/0008-5472.CAN-04-2633

Holland, 1998, Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice, Proc. Natl. Acad. Sci. USA, 95, 1218, 10.1073/pnas.95.3.1218

Holland, 1998, A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice, Genes Dev., 12, 3675, 10.1101/gad.12.23.3675

Huse, 2009, Genetically engineered mouse models of brain cancer and the promise of preclinical testing, Brain Pathol., 19, 132, 10.1111/j.1750-3639.2008.00234.x

Ino, 2000, Mutation analysis of the hCHK2 gene in primary human malignant gliomas, Neurogenetics, 3, 45, 10.1007/PL00022979

Jack, 2002, Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response, Proc. Natl. Acad. Sci. USA, 99, 9825, 10.1073/pnas.152053599

Jackson, 2009, The DNA-damage response in human biology and disease, Nature, 461, 1071, 10.1038/nature08467

Kuerbitz, 1992, Wild-type p53 is a cell cycle checkpoint determinant following irradiation, Proc. Natl. Acad. Sci. USA, 89, 7491, 10.1073/pnas.89.16.7491

Lavin, 2008, Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer, Nat. Rev. Mol. Cell Biol., 9, 759, 10.1038/nrm2514

Lee, 2006, Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines, Cancer Cell, 9, 391, 10.1016/j.ccr.2006.03.030

Liu, 2004, Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice, Nat. Genet., 36, 63, 10.1038/ng1282

Matsuoka, 1998, Linkage of ATM to cell cycle regulation by the Chk2 protein kinase, Science, 282, 1893, 10.1126/science.282.5395.1893

Miyagi, 1995, Astrocytoma linked to familial ataxia-telangiectasia, Acta Neurochir. (Wien), 135, 87, 10.1007/BF02307420

Nuciforo, 2007, Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression, Carcinogenesis, 28, 2082, 10.1093/carcin/bgm108

Parsons, 2008, An integrated genomic analysis of human glioblastoma multiforme, Science, 321, 1807, 10.1126/science.1164382

Shih, 2004, Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis, Cancer Res., 64, 4783, 10.1158/0008-5472.CAN-03-3831

Shiloh, 2003, ATM and related protein kinases: safeguarding genome integrity, Nat. Rev. Cancer, 3, 155, 10.1038/nrc1011

Stiff, 2004, ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation, Cancer Res., 64, 2390, 10.1158/0008-5472.CAN-03-3207

Stracker, 2007, The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex, Nature, 447, 218, 10.1038/nature05740

Stracker, 2008, Chk2 suppresses the oncogenic potential of DNA replication-associated DNA damage, Mol. Cell, 31, 21, 10.1016/j.molcel.2008.04.028

Takai, 2002, Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription, EMBO J., 21, 5195, 10.1093/emboj/cdf506

Theunissen, 2006, Methods for studying the cellular response to DNA damage: influence of the Mre11 complex on chromosome metabolism, Methods Enzymol., 409, 251, 10.1016/S0076-6879(05)09015-4

Ward, 2001, Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress, J. Biol. Chem., 276, 47759, 10.1074/jbc.C100569200

Ward, 2005, 53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice, Mol. Cell. Biol., 25, 10079, 10.1128/MCB.25.22.10079-10086.2005

Xu, 1996, Dual roles of ATM in the cellular response to radiation and in cell growth control, Genes Dev., 10, 2401, 10.1101/gad.10.19.2401